1261 views | 5 years ago
Dr. David Bentley, vice president and chief scientist in the clinical genomics research department at Illumina, discusses the history, goals, and milestones of the 100,000 Genome Project conducted in...
6245 views | 5 years ago
Dr. Szilard Voros, CEO of Global Genomics Group (G3), shares how he and his team of researchers embarked on an ambitious journey to transform drug discovery using big data. With 48 participating clinical...
810 views | 5 years ago
Past winners of the Illumina Greater Good Initiative share how their research was positively impacted by receiving the grant, from being able to find new genetic variants that will improve species diversity...
2044 views | 5 years ago
Find out what a polygenic risk score (PRS) is and how it can be used to predict disease risk and enable more effective treatment of complex diseases like immune disorders, cancer, heart disease, and...
1161 views | 5 years ago
Charlie Johnson, the director of genomics and bioinformatics at Texas A&M AgriLife, discusses how his lab pairs the iSeq™ 100 Sequencing System with the NovaSeq™ 6000 Sequencing System for quality control...
2598 views | 5 years ago
Charlie Johnson, the director of genomics and bioinformatics at Texas A&M AgriLife, discusses how his lab pairs the iSeq™ 100 Sequencing System with the NovaSeq™ 6000 Sequencing System for quality control...
1436 views | 5 years ago
Learn how noninvasive prenatal testing (NIPT) is making an impact around the world. Hear from the staff at AMES discuss how NIPT, particularly the Illumina VeriSeqTM NIPT solution, has helped meet an...
4504 views | 5 years ago
Hundreds of thousands of variants have been discovered. We know these variants affect cellular processes and play a part in complex diseases, but we don’t know how. Variant to function (V2F) research...